N-Methylsuccinimide in plasma and urine as a biomarker of exposure to N-methyl-2-pyrrolidone

International Archives of Occupational and Environmental Health

Volumn 74, Issue 4, 2001, Pages 289-294

  Jonsson B A G ^a   Akesson B ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Biological monitoring; Experimental exposure; N methyl 2 pyrrolidone; N methylsuccinimide

Indexed keywords

2 PYRROLIDONE DERIVATIVE; BIOCHEMICAL MARKER; ORGANIC SOLVENT; SUCCINIMIDE DERIVATIVE;

ADULT; ARTICLE; BIOLOGICAL MONITORING; BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION FUNCTION; ELECTRONICS INDUSTRY; GAS CHROMATOGRAPHY; HUMAN; INHALATION; MASS SPECTROMETRY; OCCUPATIONAL EXPOSURE; TOXICITY; URINARY EXCRETION; URINE LEVEL;

EID: 0343867218     PISSN: 03400131     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007946     Document Type: Article

References (20)

1. Åkesson B (1994) 115. N-methyl-2-pyrrolidone. Nordic expert group for criteria documentation of health risks from chemicals. Arbete Hälsa 40: 1-24
2. Åkesson B, Jönsson BAG (1997) Major metabolic pathway for N-methyl-2-pyrrolidone in humans. Drug Metab Dispos 25: 267-269
3. Åkesson B, Paulsson K (1997) Experimental exposure of male volunteers to N-methyl-2-pyrrolidone (NMP): acute effects and pharmacokinetics of NMP in plasma and urine. Occup Environ Med 54: 236-240
4. Åkesson B, Jönsson BAG (2000) Biological monitoring of N-methyl-2-pyrrolidone (NMP) using 5-hydroxy-N-methyl-2-pyrrolidone in plasma and urine as a biomarker. Scand J Work Environ Health 26: 213-218
5. Andersson B, Andersson K (1991) Determination of heterocyclic tertiary amines in air. Appl Occup Environ Hyg 6: 40-43
6. Beaulieu HJ, Schmerber KR (1991) M-pyrol (NMP) use in the microelectronics industry. Appl Occup Environ Hyg 6: 874-880
7. Becci PJ, Knickerbocker MJ, Reagan EL, Parent RA, Burnette LW (1982) Teratogenicity study of N-methylpyrrolidone after dermal application to Sprague-Dawley rats. Fundam Appl Toxicol 2: 73-76
8. Blome H, Hennig M (1984) Messung ausgewählter aliphatischer und aromatischer Aminen in der Luft von Arbeitsbereichen. Staub-Reinhalt Luft 44: 27-32
9. Hass U, Lund SP, Eisner J (1994) Effects of prenatal exposure to N-methylpyrrolidone on postnatal development and behavior in rats. Neurotoxicol Teratol 16: 241-249
10. Hass U, Jakobsen BM, Lund SP (1995) Developmental toxicity of inhaled N-methylpyrrolidone in the rat. Pharmacol Toxicol 76: 406-409
11. Horning MG, Stratton C, Nowlin J, Harlin DJ, Hill RM (1973) Metabolism of 2-ethyl-2-methylsuccinimide (ethosuximide) in the rat and human. Drug Metab Dispos 1: 569-576
12. Jönsson BAG, Åkesson B (1997a) Determination of N-methylsuccinimide in human urine and plasma. J Chromatogr 704: 151-158
13. Kuhnz W, Koch S, Jakob S, Hartmann A, Helge H, Nau H (1984) Ethosuximide in epileptic women during pregnancy and lactation period. Placental transfer, serum concentrations in nursed infants and clinical status. Br J Clin Pharmacol 18: 671-677
14. Mallow DW, Herrick MK, Gathman G (1980) Fetal exposure to anticonvulsant drugs. Arch Pathol Lab Med 104: 215-218
15. C]pyrrolidone for rats. Food Chem Toxicol 30: 57-64
16. Research Triangle Institute (1990) Absorption, distribution, metabolism and elimination of N-methyl-2-pyrrolidone in rats after oral and dermal administration. Research Triangle Institute Report RTI/3662/00-13P
17. Solomon HM, Burgess BA, Kennedy GL Jr, Staples RE (1995) 1-Methyl-2-pyrrolidone (NMP): reproductive and developmental toxicity study by inhalation in the rat. Drug Chem Toxicol 18: 271-293
18. Solomon GM, Morse EP, Garbo MJ, Milton DK (1996) Stillbirth after occupational exposure to N-methyl-2-pyrrolidone. J Occup Environ Med 38: 705-713
19. Ursin C, Hansen CM, Van Dyk JW, Jensen PO, Christensen IJ, Ebbehoej J (1995) Permeability of commercial solvents through living human skin. Am Ind Hyg Assoc J 56: 651-660
20. 14C] N-methyl-2-pyrrolidone in the rat. Drug Metab Dispos 16: 243-249